Genetic polymorphisms in host antiviral genes: Associations with humoral and cellular immunity to measles vaccine

Vaccine

Volumn 29, Issue 48, 2011, Pages 8988-8997

  Haralambieva, Iana H ^a   Ovsyannikova, Inna G ^a   Umlauf, Benjamin J ^a   Vierkant, Robert A ^a   Shane Pankratz, V ^a   Jacobson, Robert M ^a   Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Antiviral genes; Haplotypes; Immunity; Measles vaccine; Single nucleotide polymorphisms

Indexed keywords

GAMMA INTERFERON; MEASLES VACCINE; NEUTRALIZING ANTIBODY; RETINOIC ACID INDUCIBLE PROTEIN I;

AFRICAN AMERICAN; ALLELE; ARTICLE; CAUCASIAN; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GENETIC CODE; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; MALE; MEASLES VACCINATION; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS GENE;

2',5'-OLIGOADENYLATE SYNTHETASE; ADAPTIVE IMMUNITY; ADENOSINE DEAMINASE; ADOLESCENT; AFRICAN AMERICANS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHILD; DEAD-BOX RNA HELICASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; LINEAR MODELS; MALE; MEASLES; MEASLES-MUMPS-RUBELLA VACCINE; MINNESOTA; NEUTRALIZATION TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 82455175351     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.09.043     Document Type: Article

References (59)

1. Global measles mortality, 2000-2008. MMWR Morb Mortal Wkly Rep 2009, 58(December (47)):1321-1326.
2. Plemper R.K., Snyder J.P. Measles control - can measles virus inhibitors make a difference?. Curr Opin Investig Drugs 2009, 10(8):811-820.
3. Sugerman D.E., Barskey A.E., Delea M.G., Ortega-Sanchez I.R., Bi D., Ralston K.J., et al. Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated. Pediatrics 2010, 125(4):747-755.
4. Jick H., Hagberg K.W. Measles in the United Kingdom 1990-2008 and the effectiveness of measles vaccines. Vaccine 2010, 28(29):4588-4592.
5. Kennedy A.M., Gust D.A. Measles outbreak associated with a church congregation: a study of immunization attitudes of congregation members. Public Health Rep 2008, 123(2):126-134.
6. Measles - United States, January 1-April 25, 2008. MMWR Morb Mortal Wkly Rep 2008, 57(18):494-498.
7. Orenstein W.A., Strebel P.M., Hinman A.R. Building an immunity fence against measles. J Infect Dis 2007, 196(10):1433-1435.
8. Poland G.A., Ovsyannikova I.G., Jacobson R.M., Smith D.I. Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics. Clin Pharmacol Ther 2007, 82(6):653-664.
9. Poland G.A., Ovsyannikova I.G., Kennedy R.B., Haralambieva I.H., Jacobson R.M. Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections. Omics 2011, 15(9):625-636.
10. Samuel C.E. Antiviral actions of interferons. Clin Microbiol Rev 2001, 14(4):778-809.
11. Garcia-Sastre A., Biron C.A. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 2006, 312(5775):879-882.
12. Randall R.E., Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 2008, 89(Pt 1):1-47.
13. Sadler A.J., Williams B.R. Interferon-inducible antiviral effectors. Nat Rev Immunol 2008, 8(7):559-568.
14. Haralambieva I.H., Dhiman N., Ovsyannikova I.G., Vierkant R.A., Pankratz V.S., Jacobson R.M., et al. 2'-5'-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine. Hum Immunol 2010, 71(4):383-391.
15. Ovsyannikova I.G., Haralambieva I.H., Dhiman N., O'Byrne M.M., Pankratz V.S., Jacobson R.M., et al. Polymorphisms in the vitamin A receptor and innate immunity genes influence the antibody response to rubella vaccination. J Infect Dis 2010, 201(2):207-213.
16. Ovsyannikova I.G., Dhiman N., Haralambieva I.H., Vierkant R.A., O'Byrne M.M., Jacobson R.M., et al. Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes. Hum Genet 2010, 127:207-221.
17. Hijikata M., Ohta Y., Mishiro S. Identification of a single nucleotide polymorphism in the M×A gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon. Intervirology 2000, 43(2):124-127.
18. Suzuki F., Arase Y., Suzuki Y., Tsubota A., Akuta N., Hosaka T., et al. Single nucleotide polymorphism of the M×A gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection. J Viral Hepat 2004, 11(3):271-276.
19. Torisu H., Kusuhara K., Kira R., Bassuny W.M., Sakai Y., Sanefuji M., et al. Functional M×A promoter polymorphism associated with subacute sclerosing panencephalitis. Neurology 2004, 62(3):457-460.
20. King J.K., Yeh S.H., Lin M.W., Liu C.J., Lai M.Y., Kao J.H., et al. Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: a pilot study. Hepatology 2002, 36(6):1416-1424.
21. Yakub I., Lillibridge K.M., Moran A., Gonzalez O.Y., Belmont J., Gibbs R.A., et al. Single nucleotide polymorphisms in genes for 2'-5'-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection. J Infect Dis 2005, 192(10):1741-1748.
22. Knapp S., Yee L.J., Frodsham A.J., Hennig B.J., Hellier S., Zhang L., et al. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of M×A, OAS-1 and PKR. Genes Immun 2003, 4(6):411-419.
23. Hamano E., Hijikata M., Itoyama S., Quy T., Phi N.C., Long H.T., et al. Polymorphisms of interferon-inducible genes OAS-1 and M×A associated with SARS in the Vietnamese population. Biochem Biophys Res Commun 2005, 329(4):1234-1239.
24. He J., Feng D., de Vlas S.J., Wang H., Fontanet A., Zhang P., et al. Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and M×A genes: a case-control study. BMC Infect Dis 2006, 6:106-112.
25. Haralambieva I.H., Ovsyannikova I.G., O'Byrne M., Pankratz V.S., Jacobson R.M., Poland G.A. A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine. Vaccine 2011, 29(27):4485-4491.
26. Ovsyannikova IG, Haralambieva IH, Vierkant RA, Pankratz VS, Poland GA. The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity. Hum Genet 2011;(Mar), in press, doi:10.1007/s00439-011-0977-x.
27. Haralambieva I.H., Ovsyannikova I.G., Vierkant R.A., Poland G.A. Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles immunity. Clin Vaccine Immunol 2008, 15(7):1054-1059.
28. Ryan J.E., Ovsyannikova I.G., Dhiman N., Pinsky N.A., Vierkant R.A., Jacobson R.M., et al. Inter-operator variation in ELISPOT analysis of measles virus-specific IFN-gamma secreting T cells. Scand J Clin Lab Invest 2005, 65(8):681-690.
29. Ovsyannikova I.G., Dhiman N., Jacobson R.M., Vierkant R.A., Pankratz V.S., Poland G.A. HLA homozygosity does not adversely effect measles vaccine-induced cytokine responses. Virology 2007, 364(1):87-94.
30. Ryan J.E., Dhiman N., Ovsyannikova I.G., Vierkant R.A., Pankratz V.S., Poland G.A. Response surface methodology to determine optimal cytokine responses in human peripheral blood mononuclear cells after smallpox vaccination. J Immunol Methods 2009, 341(1-2):97-105.
31. Carlson C.S., Eberle M.A., Rieder M.J., Yi Q., Kruglyak L., Nickerson D.A. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004, 74(1):106-120.
32. den Dunnen J.T., Antonarakis S.E. Nomenclature for the description of human sequence variations. Hum Genet 2001, 109(1):121-124.
33. Weir B.S. Genetic data Analysis II: methods for discrete population genetic data 1996, Sinauer Associates, Inc, p. 98-9.
34. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265.
35. Schaid D.J., Rowland C.M., Tines D.E., Jacobson R.M., Poland G.A. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002, 70:425-434.
36. Storey J.D. A direct approach to false discovery rates. J R Statist Soc B 2002, 64:479-498.
37. Storey J.D., Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003, 100(16):9440-9445.
38. Dhiman N., Haralambieva I.H., Kennedy R.B., Vierkant R.A., O'Byrne M.M., Ovsyannikova I.G., et al. SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine. Immunogenetics 2010, 62(4):197-210.
39. Lim J.K., Lisco A., McDermott D.H., Huynh L., Ward J.M., Johnson B., et al. Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathogens 2009, 5(2):e1000321.
40. Dhiman N., Poland G.A., Cunningham J.M., Jacobson R.M., Ovsyannikova I.G., Vierkant R.A., et al. Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors. J Allergy Clin Immunol 2007, 120(3):666-672.
41. Clifford H.D., Richmond P., Khoo S.K., Zhang G., Yerkovich S.T., Le Souëf P.N., et al. SLAM and DC-SIGN measles receptor polymorphisms and their impact on antibody and cytokine responses to measles vaccine. Vaccine 2011, 29(33):5407-5413.
42. Ovsyannikova IG, Haralambieva IH, Vierkant RA, O'Byrne MM, Jacobson RM, Poland GA. The association of CD46, SLAM, and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses - a replication study and examination of novel polymorphisms. Hum Hered 2011; (Aug), in press.
43. Dhiman N., Ovsyannikova I.G., Vierkant R.A., Ryan J.E., Pankratz V.S., Jacobson R.M., et al. Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results. Vaccine 2008, 26(14):1731-1736.
44. Dhiman N., Ovsyannikova I.G., Cunningham J.M., Vierkant R.A., Kennedy R.B., Pankratz V.S., et al. Associations between measles vaccine immunity and single nucleotide polymorphisms in cytokine and cytokine receptor genes. J Infect Dis 2007, 195(1):21-29.
45. Haralambieva IH, Ovsyannikova IG, Kennedy RB, Vierkant RA, Pankratz VS, Jacobson RM, et al. Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination. Vaccine, 2011;(Aug), in press, doi:10.1016/j.vaccine.2011.08.083.
46. Yucesoy B., Johnson V.J., Fluharty K., Kashon M.L., Slaven J.E., Wilson N.W., et al. Influence of cytokine gene variations on immunization to childhood vaccines. Vaccine 2009, 27(50):6991-6997.
47. Haralambieva I.H., Ovsyannikova I.G., Dhiman N., Kennedy R.B., O'Byrne M., Pankratz V.S., et al. Common SNPs/Haplotypes in IL18R1 and IL18 genes are associated with variations in humoral immunity to smallpox vaccination in caucasians and African-Americans. J Infect Dis 2011, 204(3):433-441.
48. Dhiman N., Ovsyannikova I.G., Vierkant R.A., Pankratz V.S., Jacobson R.M., Poland G.A. Associations between cytokine/cytokine receptor SNPs and humoral immunity to measles, mumps and rubella in a Somali population. Tissue Antigens 2008, 72(3):211-220.
49. Moore C.B., Ting J.P. Regulation of mitochondrial antiviral signaling pathways. Immunity 2008, 28(6):735-739.
50. Yoneyama M., Fujita T. Function of RIG-I-like receptors in antiviral innate immunity. J Biol Chem 2007, 282(21):15315-15318.
51. Benn C.S., Aaby P., Bale C., Olsen J., Michaelsen K.F., George E., et al. Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa. Lancet 1997, 350(9071):101-105.
52. Soye K.J., Trottier C., Richardson C.D., Ward B.J., Miller W.H. RIG-I is required for the inhibition of measles virus by retinoids. PLoS ONE 2011, 6(7):e22323.
53. Ikegame S., Takeda M., Ohno S., Nakatsu Y., Nakanishi Y., Yanagi Y. Both RIG-I and MDA5 RNA helicases contribute to the induction of alpha/beta interferon in measles virus-infected human cells. J Virol 2010, 84(1):372-379.
54. Hu J., Nistal-Villan E., Voho A., Ganee A., Kumar M., Ding Y., et al. A common polymorphism in the caspase recruitment domain of RIG-I modifies the innate immune response of human dendritic cells. J Immunol 2010, 185(1):424-432.
55. Bonnevie-Nielsen V., Field L.L., Lu S., Zheng D.J., Li M., Martensen P.M., et al. Variation in antiviral 2',5'-oligoadenylate synthetase (2'5'AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene. Am J Hum Genet 2005, 76(4):623-633.
56. Yang J.H., Nie Y., Zhao Q., Su Y., Pypaert M., Su H., et al. Intracellular localization of differentially regulated RNA-specific adenosine deaminase isoforms in inflammation. J Biol Chem 2003, 278(46):45833-45842.
57. Umlauf BJ, Ovsyannikova IG, Haralambieva IH, Kennedy RB, Vierkant RA, Pankratz VS, et al. Correlations between vaccinia-specific immune responses within a cohort of armed forces members. Viral Immunol 2011;24(5), in press, doi:10.1089/vim.2011.0029.
58. Pichlmair A., Reis e Sousa C. Innate recognition of viruses. Immunity 2007, 27(3):370-383.
59. Martin A.M., Athanasiadis G., Greshock J.D., Fisher J., Lux M.P., Calzone K., et al. Population frequencies of single nucleotide polymorphisms (SNPs) in immuno-modulatory genes. Hum Hered 2003, 55(4):171-178.